Correlation Between Sunniva and Aequus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sunniva and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunniva and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sunniva and Aequus Pharmaceuticals, you can compare the effects of market volatilities on Sunniva and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunniva with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunniva and Aequus Pharmaceuticals.

Diversification Opportunities for Sunniva and Aequus Pharmaceuticals

0.0

Correlation Coefficient

Sunniva  Aequus Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Sunniva and Aequus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sunniva and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and Sunniva is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunniva are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of Sunniva i.e., Sunniva and Aequus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sunniva and Aequus Pharmaceuticals

Assuming the 90 days horizon Sunniva is expected to generate 4.5 times more return on investment than Aequus Pharmaceuticals. However, Sunniva is 4.5 times more volatile than Aequus Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  0.00  in Sunniva on October 11, 2024 and sell it today you would earn a total of  0.00  from holding Sunniva or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.4%
Values	Daily Returns

Sunniva  vs.  Aequus Pharmaceuticals

Sunniva

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sunniva has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sunniva is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Aequus Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Aequus Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Aequus Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sunniva and Aequus Pharmaceuticals

The main advantage of trading using opposite Sunniva and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunniva position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.

The idea behind Sunniva and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.